PfGARP | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

214 results for “PfGARP”

Trials

View all 147 →

Active, not recruiting

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

150 participants · First posted Jan 26, 2021

Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)

178 participants · First posted Mar 30, 2020

Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients

100 participants · First posted Sep 14, 2021

Drugs

View all 29 →

PF3D7-1134300

ODA-579

PARP inhibitor (Leidos)

News

View all 38 →

FAU Joins $3.8M NIH-Funded Consortium to Develop Novel Antimalarial Drugs Targeting PfGARP

Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity

PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies

Page 1 of 22